ABSTRACT
INTRODUCTION
Fibroma, thecomas, and fibrothecomas are rare benign tumors, which grow from the connective tissue of the ovarian cortex. The mean age of occurrence is 45 to 55 years. 1, 2 They are classified under sex cord-stromal tumors, which also include tumors composed of granulosa cells, theca cells, Sertoli cells, Leydig cells, and fibroblasts of stromal origin, singly or in various combinations. 3 Ovarian fibroma is a most common benign solid tumor that belongs to sex cord-stromal cell tumors of the ovary and comprises spindle-shaped fibroblastic cells and abundant collagen. 5 It accounts for 4% of all ovarian tumors. 6 Fewer than 10% of the cases are encountered under the age of 30 years. It may be functioning or nonfunctioning with endocrinal abnormalities. Affected women are asymptomatic or complain only of a palpable and progressive swelling mass in the inferior abdomen. 7 They can be unilateral in 90%
of cases, and may vary in size from 3 to 15 cm. 8 In this case, the age of presentation of ovarian fibroma is less than that reported in literature and, hence, diagnosis was not confirmed until we got the histopathology report.
A 19-year-old unmarried nulliparous girl presented to us with painful abdomen on and off. She gave no history of menstrual irregularity, vaginal discharge, or any other significant symptoms. On general clinical examination, on per abdominal examination, mass of approximately 16 weeks size of pregnant uterus was palpated in hypogastric area arising from pelvis. Mass was firm-to-hard, smooth with well-defined margin and restricted mobility. Findings were confirmed on per vaginal examination with uterus palpable separately from the mass in the right fornix. Left ovary was also palpable bulky of approximately 3 × 2 cm. Ultrasound showed large solid hypoechoic mass arising from right ovary of 7.6 × 4.8 cm, and left ovary was 3.8 × 2.9 cm. Contrast-enhanced computed tomography (CECT) abdomen showed enhancing mass lesion arising from right ovary of size 9 × 6 × 5 cm with neurotic and fibrotic component. Tumor markers: Cancer antigen (CA) 125 = 10.7; alfa fetoprotein = 0.33; lactate dehydrogenase = 220 units. Montoux was negative. The girl was planned for exploratory laparotomy in view of ovarian tumor. On laparotomy, straw-colored ascitic fluid of about 20 mL was aspirated and sent for cytology. Grossly right adnexal pedunculated mass arising from right ovary of 8 × 6 cm ( Fig. 1 ) was seen. The mass was firm-to-hard with smooth outer surface, which was excised. Left ovary was bulky with cyst of 2 × 2 cm, which was enucleated. Uterus and bilateral fallopian tubes were normal. No peritoneal deposits and no lymph nodes were palpable. Omental biopsy was done though it showed no deposits. Mass was sent for histopathological examination. Cut section of mass was solid, and hard with whorled appearance (Fig. 2) . Histopathology confirmed the diagnosis of ovarian fibroma, and the absence of malignant cells and a diagnosis of fibroma of right ovaries were given and left ovarian corpus luteal cyst was diagnosed. A meticulous search was made for any skin lesion or bony lesions, but no lesions could be detected. The patient stood the procedure well and was discharged on the 4th postoperative day.
DISCUSSION
Fibromas and thecomas belong to a spectrum of benign ovarian tumors that are derived from ovarian stroma. Fibromas are the most common sex cord tumors and account for approximately 3 to 4% of all ovarian neoplasms. 9 Ovarian fibromas are almost always benign.
Very rarely, fibromas without any atypical features are associated with peritoneal implants. 10 Fibromas are usually solid, spherical, slightly lobulated, encapsulated, gray-white masses covered by a glistening, intact ovarian serosa. 11 Fibromas should be both grossly and microscopically differentiated from thecoma and Brenner and Krukenberg tumors. Fibromas are solid, firm, and uniformly white, while thecomas have a yellow color in the cutting surface, an important feature in the differential diagnosis with fibroma. Brenner and Krukenberg tumors were excluded by negative immunoreactivity for keratin and epithelial membrane antigen.
12
Ovarian fibromas are important from an imaging standpoint because they appear as solid masses, thereby mimicking malignant neoplasms. 13 Diagnosis is essentially clinical. Cytomorphology of the fluids and serum CA125 levels may be used to rule out malignant nature of the lesion. The workup should include ultrasound of the pelvis, CT of the chest, abdomen and pelvis, magnetic resonance imaging of the pelvis, sampling of the pleural as well as the ascitic fluid, and serum markers of malignancy like CA125. 14, 15 The CECT is helpful in delineating the tumor, its origin, and preservation of fat planes. Fibroma should be differentiated from stromal hyperplasia and fibrothecoma. On CT, fibroma appears as diffuse slightly hypoattenuating masses with very slow and poor enhancement after administration of contrast media. 16, 17 Diagnosis is confirmed only on histopathology. Surgical removal of these solid ovarian tumors is recommended because of the low probability of malignancy and recurrence. 18 Laparoscopic-assisted vaginal hysterectomy can also be done, the tumor being removed in an endobag. 19 Salpingo-oophorectomy can be considered in perimenopausal or postmenopausal women, and cystectomy should be performed in young females.
CONCLUSION
Ovarian fibromas are benign tumors of the ovary, difficult to diagnose preoperatively, and can clinically and biochemically mimic ovarian cysts, tubo-ovarian mass, uterine myoma, or ovarian malignancy. Also, fibroma must be distinguished from several nonneoplastic ovarian processes, specifically massive edema, fibromatosis, and stromal hyperplasia. Imaging is helpful to diagnose, but histopathology can only confirm the diagnosis. Treatment usually consists of surgical resection either by laparotomy or laparoscopic approach. 
